Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Century Therapeutics (IPSC) Return on Assets (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Return on Assets for 4 consecutive years, with 0.1% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets rose 23.0% to 0.1% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.1%, a 23.0% increase, with the full-year FY2024 number at 0.35%, down 3.0% from a year prior.
  • Return on Assets was 0.1% for Q3 2025 at Century Therapeutics, down from 0.07% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.06% in Q1 2025 to a low of 0.38% in Q1 2024.
  • A 4-year average of 0.26% and a median of 0.3% in 2023 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: decreased -11bps in 2024, then skyrocketed 31bps in 2025.
  • Century Therapeutics' Return on Assets stood at 0.26% in 2022, then crashed by -37bps to 0.36% in 2023, then rose by 6bps to 0.34% in 2024, then skyrocketed by 71bps to 0.1% in 2025.
  • Per Business Quant, the three most recent readings for IPSC's Return on Assets are 0.1% (Q3 2025), 0.07% (Q2 2025), and 0.06% (Q1 2025).